How does Xylose Isomerase act

XYLOSOLV® supports with the help of enzymes while treating enhanced lipid levels in the blood.

The high levels of fructose (fruit sugar) contained in the foodstuffs of today cannot be decomposed by the body and is absorbed by the body via the small intestine. This may lead to enhanced lipid levels in the blood. In order to convert this excess fructose into glucose, the body needs the enzyme Xylose Isomerase (XI).

XYLOSOLV® feeds exactly this enzyme XI to the body and, in this way, can convert the excessive fructose from foodstuffs from foodstuffs to glucose in the small intestine.

XYLOSOLV® causes the conversion of excessive fructose to glucose in the small intestine. As a result of its processing, for which a patent application has been filed, the enzyme XI can be produced for the first time in the form of a capsule, and, in this way, it can be enriched within the body in the active form of a medical product. Glucose that can be utilised easily is fed easily to the body in this manner, and it is absorbed promptly by the body as a primary nutrient.

*PCT application WO2009AT00314